MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view.
ESMO Open
; 8(3): 101573, 2023 Jun.
Article
en En
| MEDLINE
| ID: mdl-37263082
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
MicroARNs
/
Diabetes Mellitus Tipo 2
/
Neoplasias
Tipo de estudio:
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
ESMO Open
Año:
2023
Tipo del documento:
Article
País de afiliación:
Italia